99. Szabo M, Gulya K (2013) Development of the microglial phenotype in culture. Neuroscience (in press, DOI 10.1016/j.neuroscience.2013.03.033).
98. Szigeti C, Bencsik N, Simonka JA, Legradi A, Kasa P, Gulya K (2013) Long-term effects of selective immunolesions of cholinergic neurons of the nucleus basalis magnocellularis on the ascending cholinergic pathways in the rat: a model for Alzheimer’s disease. Brain Res Bull 94, 9-16.
97. Gulyás B, Spenger C, Beliczai Z, Gulya K, Kása P, Jahan M, Jia Z, Weber U, Pfeifer A, Muhs A, Willbold D, Halldin C (2012) Distribution and binding of 18F-labeled and 125I-labeled analogues of ACI-80, a prospective molecular imaging biomarker of disease: a whole hemisphere post mortem autoradiography study in human brains obtained from Alzheimer's disease patients. Neurochem Int 60, 153-162.
96. Szigeti C, Sántha P, Körtvély E, Nyári T, Horváth VJ, Deák E, Dux M, Gulya K, Jancsó G (2012) Disparate changes in the expression of transient receptor potential vanilloid type 1 receptor mRNA and protein in dorsal root ganglion neurons following local capsaicin treatment of the sciatic nerve in the rat. Neuroscience 201, 320-330.
95. Budai D, Mészáros B, Zsigó A, Gulya K (2011) Differential inhibition by trifluoperazine of responses of hippocampal CA1 pyramidal cells to NMDA and AMPA in vivo. Acta Biol Szeged 55, 295-300.
94. Tökés T, Erös G, Bebes A, Hartmann P, Várszegi S, Varga G, Kaszaki J, Gulya K, Ghyczy M, Boros M (2011) Protective effects of a phosphatidylcholine-enriched diet in lipopolysaccharide-induced experimental neuroinflammation in the rat. Shock 36, 458-465.
93. Nagy AJ, Berényi A, Gulya K, Norita M, Benedek G, Nagy A (2011) Direct projection from the visual associative cortex to the caudate nucleus in the feline brain. Neurosci Lett 503, 52-57.
92. Birkas E, Bakota L, Gulya K, Wen T, Pintar J, Toth G, Szucs M (2011) A comprehensive study on the putative delta-opioid receptor (sub)types using the highly selective delta-antagonist, Tyr-Tic-(2S,3R)-beta-MePhe-Phe-OH. Neurochem Int 59, 192-201.
91. Keresztes A, Birkás E, Páhi A, Tóth G, Bakota L, Gulya K, Szücs M (2011) Pharmacology of a new tritiated endomorphin-2 analog containing the proline mimetic cis-2-aminocyclohexanecarboxylic acid. Peptides 32, 722-728.
90. Legradi A, Varszegi S, Szigeti C, Gulya K (2011) Adult rat hippocampal slices as in vitro models for neurodegeneration: studies on cell viability and apoptotic processes. Brain Research Bull 84, 39-44.
89. Gulyas B, Pavlova E, Kasa P, Gulya K, Bakota L, Varszegi S, Keller E, Horvath MC, Nag S, Hermecz I, Magyar K, Halldin C (2011) Activated MAO-B in the brain of Alzheimer patients demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography. Neurochem Int 58, 60-68.
88. Budai D, Hernádi I, Mészáros B, Bali KZ, Gulya K (2010) Electrochemical responses of carbon fiber microelectrodes to dopamine in vitro and in vivo. Acta Biol Szeged 54, 155-160.
87. Gulyas B, Brockschnieder D, Nag S, Pavlova E, Kasa P, Beliczai Z, Legradi A, Gulya K, Thiele A, Dyrks T, Halldin C (2010) The norepinephrine transporter (NET) radioligand (S,S)-[18F]FMeNER-D2 shows significant decreases in NET density in the human brain in Alzheimer’s disease: a post-mortem autoradiographic study. Neurochem Int 56, 789-798.
86. Gulyas B, Makkai B, Kasa P, Gulya K, Bakota L, Varszegi S, Beliczai Z, Andersson J, Csiba L, Thiele A, Dyrks T, Suhara T, Suzuki K, Higuchi M, Halldin C (2009) A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age matched controls using two radiolabelled DAA116 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system. Neurochem Int 54, 28-36.
85. Gulyas B, Makkai B, Nagy K, Vas A, Kasa P, Andersson J, Suhara T, Suzuki M, Higuchi M, Beliczai Z, Gulya K, Csiba L, Halldin C (2009) In vitro evidence for competitive TSPO binding of the imaging biomarker candidates vinpocetine and two iodinated DAA1106 analogues in post mortem autoradiography experiments on whole hemisphere human brain slices. Current Radiopharmaceuticals 2, 42-48.
84. Beliczai Z, Varszegi S, Gulyas B, Halldin C, Kasa P, Gulya K (2008) Immunohistoblot analysis on whole human hemispheres from normal and Alzheimer diseased brains. Neurochem Int 53, 181-183.
83. Birkas
E, Kertesz I, Toth G, Bakota L, Gulya K, Szucs M (2008) Synthesis and
pharmacological characterization of a novel, highly potent, peptidomimetic
delta-opioid radioantagonist, [3H]Tyr-Tic-(2S,3R)-beta-MePhe-Phe-OH.
Neuropeptides 42, 57-67.
82. Orojan I, Bakota L, Gulya K (2008) Trans-synaptic regulation of calmodulin gene expression after experimentally induced orofacial inflammation and subsequent corticosteroid treatment in the principal sensory and motor trigeminal nuclei of the rat. Neurochem Int 52, 265-271.
81. Orojan I, Szigeti C, Varszegi S, Gulya K (2006) Dithranol abolishes UCH-L1 immunoreactivity in the nerve fibers of the rat orofacial skin. Brain Research 1121, 216-220.
80. Orojan I, Bakota L, Gulya K (2006) Differential calmodulin gene expression in the nuclei of the rat midbrain-brain stem region. Acta Histochemica 108, 455-462.
79. Bakota L, Orojan I, Gulya K (2005) Intranuclear differences in calmodulin gene expression in the trigeminal nuclei of the rat. Acta Biol Szeged 49, 9-14.
78. Kortvely E, Burkovics P, Varszegi S, Gulya K (2005) Cloning and characterization of rat importin 9: implication for its neuronal function. Mol Brain Research 139, 103-114.
77. Palfi A, Kortvely E, Fekete E, Gulya K (2005) Multiple calmodulin mRNAs are selectively transported to functionally different neuronal and glial compartments in the rat hippocampus. An electron microscopic in situ hybridization study. Life Sciences 77, 1405-1415.
76. Vizi S, Bagosi A, Krisztin-Péva B, Gulya K, Mihaly A (2004) Repeated 4-aminopyridine seizures reduce parvalbumin content in the medial mammillary nucleus of the rat brain. Mol Brain Research 131, 110-118.
75. Kortvely E, Gulya K (2004) Calmodulin, and various ways to regulate its activity. Life Sciences 74, 1065-1070.
74. Kovacs B, Gulya K (2003) Calmodulin gene expression in the neural retina of the adult rat. Life Sciences 73, 3213-3224.
73. Szigeti C, Kovacs B, Kortvely E, Gulya K (2003) Comparison of treatment regimens to sensitize in situ hybridization for low-abundance calmodulin transcripts in the white matter of the rat spinal cord. Acta Biol Szeged 47, 1-6.
72. Kortvely E, Varszegi S, Palfi A, Gulya K (2003) Intracellular targeting of calmodulin mRNAs in primary hippocampal cells. J Histochem Cytochem 51, 541-544.
71. Kortvely E, Palfi A, Bakota L, Gulya K (2002) Ontogeny of calmodulin gene expression in rat brain. Neuroscience 114, 301-316.
70. Kovacs B, Gulya K (2002) Differential expression of multiple calmodulin genes in cells of the white matter of the rat spinal cord. Mol Brain Research 102, 28-34.
69. Palfi A, Kortvely E, Fekete E, Kovacs B, Varszegi S, Gulya K (2002) Differential calmodulin gene expression in the rodent brain. Life Sciences 70, 2829-2855.
68. Szigeti C, Fulop Z, Gulya K (2002) Branching-pattern analysis of the dendritic arborization in the thalamic nuclei of the rat brain. Acta Biol Hung 53, 177-186.
67. Csillik B, Palfi A, Gulya K, Mihaly A, Knyihar-Csillik E (2002) Somato-dendritic synapses in the nucleus reticularis thalami of the rat. Acta Biol Hung 53, 33-41.
66. Kovacs B, Gulya K (2001) A color in situ hybridization method with improved sensitivity for the detection of low-abundance mRNAs. Acta Biol Szeged 45, 75-77.
65. Vizi S, Palfi A, Hatvani L, Gulya K (2001) Methods for quantification of in situ hybridization signals obtained by film autoradiography and phosphorimaging applied for estimation of regional levels of calmodulin mRNA classes in the rat brain. Brain Research Protocols 8, 32-44.
64. Palfi A, Simonka JA, Pataricza M, Tekulics P, Lepran I, Papp G, Gulya K (2001) Postischemic calmodulin gene expression in the rat hippocampus. Life Sciences 68, 2373-2381.
63. Vizi S, Palfi A, Gulya K (2000) Multiple calmodulin genes exhibit systematically differential responses to chronic ethanol treatment and withdrawal in several regions of the rat brain. Mol Brain Research 83, 63-71.
62. Palfi A, Tarcsa M, Varszegi S, Gulya K (2000) Calmodulin gene expression in an immortalized striatal GABAergic cell line. Acta Biol Hung 51, 65-71.
61. Vizi S, Gulya K (2000) Calculation of maximal hybridization capacity (Hmax) for quantitative in situ hybridization: a case study for multiple calmodulin mRNAs. J Histochem Cytochem 48, 893-904.
60. Laskay G, Zarándi M, Jost K, Penke B, Bálint E, Ocsovszki I, Tarcsa M, Varszegi S, Gulya K (1999) ß-amyloid[1-40]-induced early hyperpolarization in M26-1F cells, an immortalized rat striatal cell line. Neurobiology 7, 431-436.
59. Palfi A, Gulya K (1999) Water deprivation upregulates the three calmodulin genes in exclusively the supraoptic nucleus of the rat brain. Mol Brain Research 74, 111-116.
58. Boros A, Temesvári P, Szöke L, Vecsernyés M, Bari F, Ábrahám CS, Pintér S, Gulya K (1999) Differential regulation of vasopressin gene expression in the hypothalamus of endotoxin-treated 14-day-old rat. Life Sciences 65, PL. 47-52.
57. Palfi A, Vizi S, Gulya K (1999) Differential distribution and intracellular targeting of mRNAs corresponding to the three calmodulin genes in rat brain: a quantitative in situ hybridization study. J Histochem Cytochem 47, 583-600.
56. Gulya K (1998) Biological activities of amyloid precursor protein. Acta Biol Hung 49, 7-27.
55. Forgon M, Farkas Z, Gulya K, Pakaski M, Penke B, Kasa P (1998) Amyloid ß-peptide and its fragments induce acetylcholine release in in vitro basal forebrain tissue slices of rat brain, but do not affect the choline uptake. Neurobiology 6, 359-361.
54. Bakota L, Szikra J, Toth G, Gulya K (1998) Slide-binding characterization and autoradiographic localization of delta opioid receptors in rat and mouse brains with the tetrapeptide antagonist [3H]TIPP. Life Sciences 63, 1377-1385.
53. Palfi A, Hatvani L, Gulya K (1998) A new quantitative film autoradiographic method of quantifying mRNA transcripts for in situ hybridization. J Histochem Cytochem 46, 1141-1149.
52. Harkany T, O’Mahony S, Kelly JP, Soós K, Törö I, Penke B, Luiten PGM, Nyakas C, Gulya K, Leonard BE (1998) ß-amyloid(Phe(SO3H)24)25-35 in rat nucleus basalis magnocellularis induces behavioural dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation. Behav Brain Research 90, 133-145.
51. Kása P, Rakonczay Z, Gulya K (1997) The cholinergic system in Alzheimer’s disease. Progr Neurobiol 52, 511-535.
50. Humphries MMB, Farrar GJ, Kenna P, Rancourt D, Hazel M, Bush R, Sieving P, Shiels D, McNally N, Creighton P, Erven ASW, Boros A, Gulya K, Capecchi M, Humphries P (1997) Retinopathy induced in mice by targeted disruption of the rhodopsin gene. Nature Genetics 15, 216-219.
49. Harkany T, Lengyel Z, Kása P, Gulya K (1996) Chronic aluminum treatment results in aluminum deposits and affects M1 muscarinic receptors in rat brain. Neurobiology 4, 35-43.
48. Harkany T, De Jong GI, Soós K, Penke B, Liuten PGM, Gulya K (1995) ß-amyloid(1-42) affects cholinergic but not parvalbumin-containing neurons in the septal complex of the rat. Brain Research 698, 270-274.
47. Harkany T, Lengyel Z, Soós K, Penke B, Luiten PGM, Gulya K (1995) Cholinotoxic effects of ß-amyloid(1-42) peptide on the cortical projections of the rat nucleus basalis magnocellularis. Brain Research 695, 71-75.
46. Gulya K, Szikra J, Kása P (1995) (D-Pen2, D-Pen5)enkephalin, a delta opioid receptor agonist, reduces endogenous aluminum content in the rat central nervous system. Neuroscience 66, 499-506.
45. Gulya K (1994) Muscarinergic and neuropeptidergic receptor heterogeneity and signal transduction. Acta Biol Szeged 40, 141-150.
44. Pálfi A, Gulya K (1994) Effects of anticholinesterases on muscarinic receptor binding properties in the rat brain. Acta Biol Szeged 40, 37-40.
43. Gulya K, Szikra J, Kása P (1994) Delta opioid system regulates endogenous metal ion contents in rat striatum and medulla. Life Chemistry Reports 11, 125-139.
42. Gulya K, Orpana AK, Sikela JM, Hoffman PL (1993) Prodynorphin and vasopressin mRNA levels are differentially affected by chronic ethanol ingestion in the mouse. Mol Brain Research 20, 1-8.
41. Gulya, K, Dave J, Hoffman PL (1991) Chronic ethanol ingestion decreases vasopressin mRNA in hypothalamic and extrahypothalamic nuclei of mouse brain. Brain Research 557, 129-135.
40. Gulya K, Grant K, Valverius P, Hoffman PL, Tabakoff B (1991) Brain regional specificity and time course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Research 547, 129-134.
39. Gulya K, Kovács GL, Kása P (1991) Regulation of endogenous calcium and magnesium levels by delta opioid receptors in the rat brain. Brain Research 547, 22-27.
38. Gulya K, Kovács GL, Kása P (1991) Partial depletion of endogenous zinc level by (D-Pen2, D-Pen5)enkephalin in the rat central nervous system. Life Sciences 48, PL.57-62.
37. Hoffman PL, Ishizawa H, Giri PR, Dave JR, Gran, KA, Liu L-I, Gulya K, Tabakoff B (1990) The role of arginine vasopressin in alcohol tolerance. Annals of Medicine 22, 269-274.
36. Gulya K (1990) The opioid system in neurologic and psychiatric disorders and in their experimental models. Pharmacol Therap 46, 395-428.
35. Gulya K, Rakonczay Z, Kása P (1990) Cholinotoxic effects of aluminum in rat brain. J Neurochem 54, 1020-1026.
34. Tekulics P, Rakonczay Z, Szerdahelyi P, Kása P, Gulya K (1990) Effects of ischemia on cholinergic neurotransmission and electrolyte content in newborn pig lumbar spinal cord. Life Sciences 46, 811-817.
33. Kriván M, Nyolczas N, Sarnyai Z, Szabó G, Gulya K, Kovács GL, Telegdy G (1989) Effect of a selective ∂-opioid agonist, D-Pen2-D-Pen5-enkephalin (DPDPE), on grooming and sniffing activity. Int J Psychophysiol 7, 275-276.
32. Szabó A, Nemcsók J, Kása P, Gulya K (1989) Muscarinic cholinergic system in the carp brain. Neurochem Int 15, 511-516.
31. Gulya K, Budai D, Kása P (1989) Muscarinic autoreceptors are differentially affected by selective muscarinic antagonists. Neurochem Int 15, 153-156.
30. Fatranska M, Budai D, Gulya K, Kvetnansky R (1989) Changes in acetylcholine content, release and muscarinic receptors in rat hippocampus under cold stress. Life Sciences 45, 143-149.
29. Gulya K, Simonka JA, Kása P (1989) Transport of muscarinic cholinergic marker protein activities in regenerating sciatic nerve of rat. J Neurochem 53, 179-182.
28. Hawkins KN, Knapp RJ, Lui GK, Gulya K, Kazmierski W, Wan Y-P, Pelton JT, Hruby VJ, Yamamura HI (1989) (3H)-(H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 ((3H)CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain. J Pharmacol Exp Ther 248, 73-80.
27. Gulya K, Tekulics P, Kása P (1989) Effects of ischemia on mu opioid receptors in newborn pig lumbar spinal cord. Acta Biol Hung 40, 229-235.
26. Tekulics P, Rakonczay Z, Dobó E, Kása P, Kovács J, Gulya K (1988) A kolinerg rendszer elemeinek változása ischaemia hatására újszülött malacok lumbalis gerincvelö szakaszában. Gyermekgyógyászat 39, 406-411. Changes in the cholinergic system in the ischemic lumbal spinal cord of newborn pig (in Hungarian).
25. Gulya K, Kriván M, Nyolczas N, Sarnyai Z, Kovács GL (1988) Central effects of the potent and highly selective mu-opioid antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) in mice. Eur J Pharmacol 150, 355-360.
24. Kovács GL, Nyolczas N, Kriván M, Gulya K (1988) Analgesic and tolerance-inducing effects of the highly selective delta-opioid agonist (D-Pen2, D-Pen5)enkephalin in mice. Eur J Pharmacol 150, 347-353.
23. Wang J-X, Roeske WR, Gulya K, Wang W, Yamamura HI (1987) (3H)AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart. Life Sciences 41, 1751-1760.
22. Hawkins KN, Morelli M, Gulya K, Chang K-J, Yamamura HI (1987) Autoradiographic localization of (3H)(MePhe3, D-Pro4)morphiceptin ((3H)PLO17) to mu opioid receptors in rat brain. Eur J Pharmacol 133, 351-352.
21. Watson M, Roeske WR, Vickroy TW, Smith TL, Akiyama K, Gulya K, Duckles SP, Serra M, Adem A, Nordberg A, Gehlert D, Wamsley JK, Yamamura HI (1986) Biochemical and functional basis of putative muscarinic receptor subtypes and its implications. In: Subtypes of Muscarinic Receptors II. Trends Pharmacol Sci Suppl. 46-55.
20. Pelton JT, Kazmierski W, Gulya K, Yamamura HI, Hruby VJ (1986) Design and synthesis of conformationally constrained somatostatin analogs with high potency and specificity for mu opioid receptors. J Med Chem 29, 2370-2375.
19. Gulya K, Gehlert D, Wamsley JK, Mosberg HI, Hruby VJ, Yamamura HI (1986) Light microscopic autoradiographic localization of delta opioid receptors in the rat brain using a highly selective bis-penicillamine cyclic enkephalin analogue. J Pharmacol Exp Ther 238, 720-726.
18. Gulya K, Pelton JT, Hruby VJ, Yamamura HI (1986) Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors. Life Sciences 38, 2221-2229.
17. Darman PS, Landis GC, Smits JR, Hirning LD, Gulya K, Yamamura HI, Burks TF, Hruby VJ (1985) Conformationally restricted cyclic analogues of substance P: Insight into the receptor binding process. Biochem Biophys Res Comm 127, 656-662.
16. Gulya K, Gehlert D, Wamsley JK, Mosberg HI, Hruby VJ, Duckles SP, Yamamura HI (1985) Autoradiographic localization of delta opioid receptors in the brain using a highly selective bis-penicillamine enkephalin analog. Eur J Pharmacol 111, 285-286.
15. Gulya K, Wamsley JK, Gehlert D, Pelton JT, Hruby VJ, Duckles SP, Yamamura HI (1985) Light microscopic autoradiographic localization of somatostatin receptors in the rat brain. J Pharmacol Exp Ther 235, 254-258.
14. Pelton JT, Gulya K, Hruby VJ, Duckles SP, Yamamura HI (1985) Conformationally restricted analogs of somatostatin with high mu opiate receptor specificity. Proc Natl Acad Sci USA 82, 236-239.
13. Pelton JT, Gulya K, Hruby VJ, Duckles SP, Yamamura HI (1985) Somatostatin analogs with affinity for opiate receptors in rat brain binding assay. Peptides 6, 159-163.
12. Kása P, Dames W, Rakonczay Z, Gulya K, Joó F, Wolff JR (1985) Modulation of the acetylcholine system in the superior cervical ganglion of rat: Effects of GABA and hypoglossal nerve implantation after in vivo GABA treatment. J Neurochem 44, 1363-1372.
11. Gulya K, Budai D, Kása P, Rakonczay Z (1984) In vivo effects of ß-bungarotoxin on the acetylcholine system in different brain areas of rat. J Neurochem 43, 112-119.
10. Gulya K, Kása P (1984) Transport of muscarinic cholinergic receptors in the sciatic nerve of rat. Neurochem Int 6, 123-126.
9. Laskay G, Farkas T, Lehoczki E, Gulya K (1983) Effects of pyridazinone herbicides during chloroplast development in detached barley leaves II. Effects on lipid content, fatty acid composition and ultrastructure of chloroplast. Z Naturforschung 38c, 741-747.
8. Gulya K, Kása P (1983) Subcellular distribution and postnatal development of cholinergic marker proteins in the striatum of rat. Acta Biol Hung 34, 395-405.
7. Gulya K, Kása P (1983) Structural localization of the elements of the acetylcholine system in the rat cerebellum. Acta Biol Hung 34, 155-161.
6. Kása P, Bánsághy K, Gulya K (1982) Ultrastructural changes and diffusion of acetylcholine in rat brain after microwave irradiation. J Neurosci Meth 5, 215-220.
5. Dóczi T, Szerdahelyi P, Gulya K, Kiss J (1982) Brain water accumulation after central administration of vasopressin. Neurosurgery 11, 402-407.
4. Kása P, Bánsághy K, Rakonczay Z, Gulya K (1982) Postnatal development of the acetylcholine system in different parts of the rat cerebellum. J Neurochem 39, 1726-1732.
3. Kása P, Szepesy G, Gulya K, Bánsághy K, Rakonczay Z (1982) The effect of 4-(1-naphthylvinyl)-pyridine on the acetylcholine system and on the number of synaptic vesicles in the central nervous system of the rat. Neurochem Int 4, 185-193.
2. Simonka JA, Gulya K (1982) Új módszer a kísérletes idegvarratok pásztázó elektronmikroszkópos vizsgálatára. Kísérletes Orvostudomány 34, 498-502. A new scanning electronmicroscopic method for the study of the nerve sutures (in Hungarian).
1. Gulya K, Szepesy G, Bánsághy K, Kása P (1981) Az acetilkolin tartalom és a szinaptikus vezikulák számának regulációja a központi idegrendszerben. Kísérletes Orvostudomány 33, 362-368. Regulation of ACh content and the number of synaptic vesicles in the central nervous system (in Hungarian).
10. Gulya K, Szikra J, Lengyel Z, Harkány T, Kása P (1993) Interaction between the endogenous opioid system and the aluminum content in rat striatum. In: Recent Advances in Aging Science, Acta of the XVth Gerontology World Congress (Eds.: E Beregi, IA Gergely, K Rajczi), Budapest, 1993, Monduzzi Editore S. p. A., Bologna, Italy, p. 631-635.
9. Roeske WR, Wang J-X, Gulya K, Korc M, Serra M, Ackerman M, Mei L, Vickroy T, Watson M, Yamamura HI (1987) Biochemical, functional and anatomic evidence for putative muscarinic receptor subtypes using selective antagonists (3H)AF-DX 116 and (3H)pirenzepine. In: Cellular and Molecular Basis of Cholinergic Function (Eds.: Dowdall MJ, Hawthorne JM), Ellis Horwood Ltd., Chichester, England and VCH Weinheim, F.R.G., Weinheim-New York, 64-71.
8. Hruby VJ, Kao L-F, Shook JE, Gulya K, Yamamura HI, Burks TF (1987) Design and synthesis of receptor selective peptide neurotransmitters. In: Peptides 1986, Proceedings of the 19th European Peptide Symposium, Porto Carras, Greece, August 31-Sept. 5, 1986. (Ed.: D Theodoropoulos), Walter de Gruyter & Co., Berlin-New York, 385-388.
7. Gulya K, Lui GK, Pelton JT, Kazmierski W, Hruby VJ, Yamamur HI (1986) H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2: A potent and selective antagonist for mu opioid receptors. In: National Institute on Drug Abuse Research Monograph No. 75. Progress in Opioid Research. Proceedings of the 1986 I.N.R.C. Advances in Endogenous and Exogenous Opioid Peptides (ed.: Holaday JW), 209-212.
6. Wang J-X, Gulya K, Vickroy TW, Watson M, Mei L, Roeske WR, Perry EK, Perry R, Fibiger HC, Yamamura HI (1986) Alterations of cholinergic and somatostatin systems in Alzheimer's disease and its animal models. In: Liver and Aging -1986, Liver and Brain (Ed.: Kitani K), Elsevier Science Publishers B.V. (Biomedical Division), 209-220.
5. Gulya K, Pelton JT, Gehlert DR, Wamsley JK, Duckles SP, Hruby VJ, Yamamura HI (1986) Conformationally restricted penicillamine analogs with high selectivity for delta and mu opioid receptors. In: Neural and Endocrine Peptides and Receptors (Ed.: TW Moody), Plenum Press, New York - London, 567-580.
4. Gulya K, Watson M, Vickroy TW, Roeske WR, Perry R, Perry E, Duckles SP, Yamamura HI (1986) Examination of cholinergic and neuropeptide receptor alterations in senile dementia of Alzheimer's type (SDAT). In: Advances in Behavioral Biology, Vol. 29: Alzheimer's and Parkinson's diseases: Strategies for Research and Development (Eds.: A Fisher, I Hanin, C Lachman), Plenum Press, New York - London, 109-116.
3. Pelton JT, Cody WL, Hruby VJ, Gulya K, Hirning LD, Yamamura HI, Burks TF (1985) Conformation and design of cyclic somatostatin analogs with high affinity for mu opiate receptors. In: Peptides: Structure and Function, Proceedings of the 9th American Peptide Symposium (Eds.: CM Deber, VJ Hruby, KD Kopple), Pierce Chemical Company Press, 623-626.
2. Gulya K, Szepesy G, Kása P (1981) Effects of NVP on the number of synaptic vesicles of rat cerebellum. In: Drugs, Biochemistry and Metabolism (Eds.:I Klebovich, I Laszlovszky, B Rosdy), Biochem. Sect. Hungarian Chem. Soc., Budapest, 57-60.
1. Kása P, Szepesy G, Gulya K, Bánsághy K (1981) Regulation of acetylcholine synthesis in the central nervous system of rat. In: Adv. Physiol. Sci., Vol. 36: Analogues of Conditioning and Neural Plasticity (Eds.: O Fehér, F Joó), Akadémiai Kiadó - Pergamon Press, Budapest-Oxford, 299-312.
4. Gulya K (2000) Neurocitológia. SZTE TTK, Szeged 2000. Neurocytology
(in Hungarian)
3. Bakota L, Gulya K (1998) Sejtbiológia. JATE TTK, Szeged 1998. Cell Biology (in Hungarian)
2. Osvay K, Gulya K (1998) (eds.): Scientific and educational activity at the Faculty of Sciences of JATE University 1995-1997. (in English) JATE TTK, Szeged 1998, ISBN 963 482 321 6
1. Osvay K, Gulya K (1997) (eds.): A József Attila Tudományegyetem Természettudományi Karának oktatási és kutatási tevékenysége 1995-1996. (in Hungarian) JATE TTK, Szeged 1997, ISBN 963 482 042 5